LQDA 28.85 ▲ 0.03% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Liquidia Corporation

    NASDAQ: LQDA · Real-Time Price · USD
    28.85
    0.01 (0.03%)
    At close: Sep 05, 2025, 3:59 PM
    28.85
    0.00%
    After-hours: Sep 05, 2025, 04:42 PM EDT
    0.03%
    Bid 27.85
    Market Cap 2.48B
    Revenue (ttm) 19.32M
    Net Income (ttm) -99.89M
    EPS (ttm) -1.82
    PE Ratio (ttm) -15.85
    Forward PE 45.06
    Analyst Buy
    Ask 29.7
    Volume 1,396,530
    Avg. Volume (20D) 2,768,591
    Open 29.25
    Previous Close 28.84
    Day's Range 28.28 - 29.43
    52-Week Range 8.75 - 29.94
    Beta 0.23

    About LQDA

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol LQDA
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for LQDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Liquidia Corporation is scheduled to release its earnings on Nov 12, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    3 weeks ago
    +13.68%
    Liquidia shares are trading higher. The company re... Unlock content with Pro Subscription
    2 months ago
    -16.87%
    Liquidia shares are trading lower in reaction to Insmed after its drug to treat rare lung disease met its primary endpoint and all secondary efficacy endpoints.
    news image

    3 weeks ago · benzinga.com

    Liquidia Analysts Raise Their Forecasts Following Q2 Results

    Liquidia Corporation LQDA reported a loss for the second quarter on Tuesday.

    news image

    3 weeks ago · zacks.com

    Liquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Beats Revenue Estimates

    Liquidia Technologies, Inc. (LQDA) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.37 per share a year ago.

    news image

    3 weeks ago · benzinga.com

    Why Is Liquidia Stock Trading Higher On Tuesday?

    Liquidia Corporation LQDA reported on Tuesday a second-quarter loss of 49 cents, missing the consensus of a loss of 43 cents.

    news image

    3 weeks ago · seekingalpha.com

    Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

    Liquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript

    news image

    2 months ago · seekingalpha.com

    What Next For Liquidia After Launch?

    Liquidia shipped its first FDA-approved product, Yutrepia for pulmonary hypertension in June entering market worth several billion dollars. Market sentiment remains skeptical, pricing in limited Yutre...

    news image

    2 months ago · https://thefly.com

    Liquidia price target lowered by $2 at BofA, here's why

    Liquidia -2.845 (-15.80%) Insmed +19.21 (+27.19%) 17 Jun

    Add to Watchlist